The discovery of this nano-scale regulation mediated by KIF12 kinesin will therefore accelerate the elucidation of anti-MASH molecular machinery, and stimulate next-generation translational research into kinesins on the regulation of refractory metabolic diseases. This evidence concerns the gene KIF12 and metabolic disease.